(Q50532472)

14 March 2018

title

Pale neurites, premature α-synuclein aggregates with centripetal extension from axon collaterals. (English)

1 reference

14 March 2018

1 reference

1 reference

Toshiro Kanazawa

1

1 reference

14 March 2018

Eijiro Adachi

2

1 reference

14 March 2018

Satoshi Orimo

3

1 reference

14 March 2018

Ayako Nakamura

4

1 reference

14 March 2018

Hidehiro Mizusawa

5

1 reference

14 March 2018

Toshiki Uchihara

6

1 reference

14 March 2018

publication date

16 August 2011

1 reference

14 March 2018

published in

Brain Pathology

1 reference

14 March 2018

volume

22

1 reference

14 March 2018

issue

1

1 reference

14 March 2018

page(s)

67-78

1 reference

14 March 2018

Profound cardiac sympathetic denervation occurs in Parkinson disease

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Staging of brain pathology related to sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Semiconductor nanocrystals as fluorescent biological labels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Axon pathology in neurological disease: a neglected therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

The brain-stem lesions in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Lewy bodies are ubiquitinated. A light and electron microscopic immunocytochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Ultrastructural observations in Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Accumulation of phosphorylated alpha-synuclein in aging human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Application of silver degeneration stains for neurotoxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Silver diagnosis in neuropathology: principles, practice and revised interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1750-3639.2011.00509.X

10.1111/J.1750-3639.2011.00509.X

21 January 2018

Identifiers

DOI

1 reference

14 March 2018

PubMed ID

21672073

1 reference

14 March 2018